We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • Drug Products
    • Books
    • Books Library
    • Events
    • Form 483s
    • Subscription Newsletters
    • Free Newsletters
    • Training
    • Webinar Training Pass
  • Device Products
    • Books
    • Books Library
    • Events
    • Form 483s
    • Subscription Newsletters
    • Free Newsletters
    • Training
    • Webinar Training Pass
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Webinar Recordings » The Biopharmaceutical Facility of the Future - Webinar CD/Transcript

Other Options

Audio CD/Transcript - Sept. 29, 2015

$287.00

Audio CD/Transcript - Sept. 29, 2015

$258.00

Audio CD/Transcript - Sept. 29, 2015

$244.00

Audio CD/Transcript - Sept. 29, 2015

$230.00

Audio CD/Transcript - Sept. 29, 2015

$215.00

The Biopharmaceutical Facility of the Future - Webinar CD/Transcript

$287.00
Webinar Recordings

Product Details

The Biopharmaceutical Facility of the Future: To 2025 and Beyond

The biopharmaceutical facilities that we design, build and renovate today — while evolving to accommodate new process technology and multiple products — will bear little resemblance to facilities of the future. Drivers of transformation in the industry include:

    • Global regulatory harmonization
    • Return on investment
    • Relocation/adaptation to areas with more favorable tax structures
    • Speed of product introduction
    • Scalability at a rapid pace, as needed
    • The ability to repurpose a facility, process or equipment instantly
    • Mergers, acquisitions, and divestiture

Manufacturers will continue to focus on large molecules, novel delivery systems, and continuous processing; they’ll use small batch sizes to accommodate both the requirements of lower risk for high-value and high-volume products, and more individualized medicines. Thus, the facilities, processes, and filling will be profoundly different, even as the packaging remains recognizable. The financial drivers mentioned above will force a revolution in the process area, and we’ll see developments such as:

    • Fully contained and disposable process equipment
    • Inert system with no exposure to any atmosphere
    • Pod-based, autonomous facilities/rooms
    • Robotic assembly/disassembly of processes
    • Humans existing only in ISO 8 environments
    • PAT- and sensor-based quality control and release

Herman and Erich Bozenhardt will explore the commercial factors which are driving the industry — and often not towards success. Second, they’ll discuss the establishment of a joint global regulatory agency. Based on the business aspects, they’ll define future process requirements and provide a view of how change is accelerating from evolution to revolution. Finally, with the processes designed, they’ll discuss what manufacturing plants will eventually become and how they’ll support compliant production.

You will get an inside-out view of a future plant’s design model: Process Core, Facility Design, Facility Operations, HVAC, Utilities, and Construction. This presentation will explore these critical aspects, expose you to technologies available today from a design and compliance perspective, and provide you with specific guidelines and direction on how you can use them right now.

Specifically you will learn:

  • The process technologies driving the future of the business
  • A glimpse of the minimalist, modular state that companies will evolve towards
  • The future of compliance — a singular “bullet-proof” concept without contamination
  • What you can do today to enhance your production and become part of the revolution
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578.

Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing